␣-Galactosidases catalyze the hydrolysis of terminal ␣-1,6-galactosyl units from galacto-oligosaccharides and polymeric galactomannans. The crystal structures of tetrameric Saccharomyces cerevisiae ␣-galactosidase and its complexes with the substrates melibiose and raffinose have been determined to 1.95, 2.40, and 2.70 Å resolution. The monomer folds into a catalytic (␣/) 8 barrel and a C-terminal -sandwich domain with unassigned function. This pattern is conserved with other family 27 glycosidases, but this enzyme presents a unique 45-residue insertion in the -sandwich domain that folds over the barrel protecting it from the solvent and likely explaining its high stability. The structure of the complexes and the mutational analysis show that oligomerization is a key factor in substrate binding, as the substrates are located in a deep cavity making direct interactions with the adjacent subunit. Furthermore, docking analysis suggests that the supplementary domain could be involved in binding sugar units distal from the scissile bond, therefore ascribing a role in fine-tuning substrate specificity to this domain. It may also have a role in promoting association with the polymeric substrate because of the ordered arrangement that the four domains present in one face of the tetramer. Our analysis extends to other family 27 glycosidases, where some traits regarding specificity and oligomerization can be formulated on the basis of their sequence and the structures available. These results improve our knowledge on the activity of this important family of enzymes and give a deeper insight into the structural features that rule modularity and protein-carbohydrate interactions.Galactose is present in the oligosaccharides of many plant seeds and is also essential in structures as the hemicelluloses. These polymers build up the plant cell wall and represent a huge storage of carbon within the biosphere and might be an important source of renewable energy (1). In humans, mutations of the ␣-galactosidase gene cause incomplete degradation of glycolipids and glycoproteins, resulting in Fabry disease (2). Different strategies involving recombinant ␣-galactosidases are being developed for the treatment of this disease. Another interesting application is the conversion between the ABO blood groups, determined by differences in polysaccharide structures present in the surface of red blood cells. Some ␣-galactosidases are able to remove the ␣-linked terminal galactose that differs between O antigen (universal blood) and B antigen, and processes involving plant ␣-galactosidases are being developed to obtain O-type blood from B-type donors (3). Furthermore, the activity of ␣-galactosidase is of great interest in many biotechnological applications. It is used to improve the quality and yield of sucrose in the sugar beet industry by achieving an efficient raffinose and other galacto-oligosaccharide hydrolyses. In addition, the processing of soybean-related products and other legume-derived food with this enzyme reduces the content of...